Millennium Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.8M | Sell |
30,823
-334,841
| -92% | -$156M | 0.01% | 1864 |
|
|
2025
Q4 | $166M | Buy |
365,664
+324,622
| +791% | +$140M | 0.07% | 252 |
|
|
2025
Q3 | $16.1M | Buy |
+41,042
| New | +$17.2M | 0.01% | 1913 |
|
|
2025
Q2 | – | Sell |
-309,935
| Closed | -$143M | – | 6367 |
|
|
2025
Q1 | $150M | Sell |
309,935
-708
| -0.2% | -$330K | 0.08% | 226 |
|
|
2024
Q4 | $125M | Buy |
310,643
+151,349
| +95% | +$70.2M | 0.06% | 309 |
|
|
2024
Q3 | $74.1M | Buy |
159,294
+16,535
| +12% | +$7.94M | 0.04% | 589 |
|
|
2024
Q2 | $66.9M | Sell |
142,759
-182,057
| -56% | -$79M | 0.03% | 624 |
|
|
2024
Q1 | $136M | Sell |
324,816
-317,934
| -49% | -$134M | 0.06% | 330 |
|
|
2023
Q4 | $262M | Buy |
642,750
+97,421
| +18% | +$36M | 0.11% | 129 |
|
|
2023
Q3 | $190M | Sell |
545,329
-521,389
| -49% | -$182M | 0.1% | 153 |
|
|
2023
Q2 | $375M | Buy |
1,066,718
+1,059,682
| +15,061% | +$357M | 0.19% | 50 |
|
|
2023
Q1 | $2.22M | Sell |
7,036
-329,526
| -98% | -$98.8M | ﹤0.01% | 3346 |
|
|
2022
Q4 | $97.2M | Buy |
336,562
+333,024
| +9,413% | +$101M | 0.05% | 392 |
|
|
2022
Q3 | $1.02M | Sell |
3,538
-287,965
| -99% | -$82.9M | ﹤0.01% | 4321 |
|
|
2022
Q2 | $82.1M | Sell |
291,503
-21,633
| -7% | -$5.79M | 0.05% | 384 |
|
|
2022
Q1 | $81.7M | Sell |
313,136
-133,717
| -30% | -$31.7M | 0.04% | 429 |
|
|
2021
Q4 | $98.1M | Sell |
446,853
-248,855
| -36% | -$48.4M | 0.05% | 368 |
|
|
2021
Q3 | $126M | Buy |
695,708
+331,296
| +91% | +$64.7M | 0.08% | 234 |
|
|
2021
Q2 | $73.5M | Sell |
364,412
-541,509
| -60% | -$113M | 0.05% | 432 |
|
|
2021
Q1 | $195M | Buy |
905,921
+592,174
| +189% | +$130M | 0.14% | 91 |
|
|
2020
Q4 | $74.2M | Buy |
313,747
+269,398
| +607% | +$61.8M | 0.05% | 302 |
|
|
2020
Q3 | $12.1K | Sell |
44,349
-106,592
| -71% | -$29.4M | 0.01% | 1109 |
|
|
2020
Q2 | $43.8M | Buy |
150,941
+57,693
| +62% | +$15.6M | 0.06% | 338 |
|
|
2020
Q1 | $22.2M | Sell |
93,248
-304,556
| -77% | -$69.9M | 0.05% | 406 |
|
|
2019
Q4 | $87.1M | Sell |
397,804
-3,685
| -0.9% | -$746K | 0.11% | 180 |
|
|
2019
Q3 | $68M | Sell |
401,489
-99,114
| -20% | -$17.5M | 0.11% | 206 |
|
|
2019
Q2 | $91.8M | Sell |
500,603
-109,608
| -18% | -$19.2M | 0.14% | 148 |
|
|
2019
Q1 | $112M | Sell |
610,211
-620,640
| -50% | -$115M | 0.17% | 120 |
|
|
2018
Q4 | $204M | Buy |
1,230,851
+222,524
| +22% | +$38.6M | 0.32% | 41 |
|
|
2018
Q3 | $194M | Buy |
1,008,327
+344,730
| +52% | +$61.4M | 0.24% | 60 |
|
|
2018
Q2 | $113M | Buy |
663,597
+95,048
| +17% | +$14.7M | 0.15% | 162 |
|
|
2018
Q1 | $92.7M | Sell |
568,549
-659,534
| -54% | -$108M | 0.12% | 212 |
|
|
2017
Q4 | $184M | Sell |
1,228,083
-440,125
| -26% | -$65.2M | 0.25% | 43 |
|
|
2017
Q3 | $254M | Buy |
1,668,208
+890,742
| +115% | +$134M | 0.39% | 17 |
|
|
2017
Q2 | $100M | Sell |
777,466
-229,594
| -23% | -$27.6M | 0.18% | 109 |
|
|
2017
Q1 | $110M | Buy |
1,007,060
+461,460
| +85% | +$40.6M | 0.2% | 99 |
|
|
2016
Q4 | $40.2M | Buy |
545,600
+246,864
| +83% | +$20.1M | 0.08% | 329 |
|
|
2016
Q3 | $26.1M | Buy |
298,736
+296,133
| +11,377% | +$28M | 0.04% | 479 |
|
|
2016
Q2 | $224K | Sell |
2,603
-677,053
| -100% | -$58.5M | ﹤0.01% | 2858 |
|
|
2016
Q1 | $54M | Sell |
679,656
-720,481
| -51% | -$65.2M | 0.14% | 165 |
|
|
2015
Q4 | $176M | Sell |
1,400,137
-179,237
| -11% | -$21.6M | 0.37% | 29 |
|
|
2015
Q3 | $164M | Buy |
1,579,374
+1,167,738
| +284% | +$150M | 0.32% | 42 |
|
|
2015
Q2 | $50.8M | Buy |
411,636
+322,607
| +362% | +$40.7M | 0.1% | 252 |
|
|
2015
Q1 | $10.5M | Sell |
89,029
-666,095
| -88% | -$79.8M | 0.02% | 990 |
|
|
2014
Q4 | $89.7M | Buy |
755,124
+282,174
| +60% | +$31.8M | 0.19% | 87 |
|
|
2014
Q3 | $53.1M | Sell |
472,950
-18,272
| -4% | -$1.74M | 0.13% | 150 |
|
|
2014
Q2 | $46.5M | Buy |
491,222
+257,408
| +110% | +$18M | 0.13% | 155 |
|
|
2014
Q1 | $16.5M | Buy |
233,814
+123,763
| +112% | +$9.8M | 0.05% | 538 |
|
|
2013
Q4 | $8.18M | Sell |
110,051
-211,203
| -66% | -$14.7M | 0.03% | 839 |
|
|
2013
Q3 | $24.4M | Buy |
321,254
+61,313
| +24% | +$4.88M | 0.08% | 266 |
|
|
2013
Q2 | $20.8M | Buy |
+259,941
| New | +$19.1M | 0.06% | 299 |
|
Other funds holding VRTX
VCM
VPM
Millennium Management's VRTX Position: Q1 2026 in Review
Millennium Management reduced its Vertex Pharmaceuticals (VRTX) stake by 92% in Q1 2026, selling an estimated $156M and leaving 30,823 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #1864.
Millennium Management first reported a position in VRTX in Q2 2013 and has held it in 51 quarters since. The position peaked at $375M in Q2 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Millennium Management held 30,823 shares of Vertex Pharmaceuticals worth $13.8M as of Q1 2026.
- Millennium Management sold 334,841 Vertex Pharmaceuticals shares in Q1 2026, an estimated $156M.
- Vertex Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1864 holding.
- Millennium Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Millennium Management's Vertex Pharmaceuticals position peaked at $375M in Q2 2023.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.